BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma X, Zhang W, Jiang Y, Wen J, Wei S, Zhao Y. Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review. Front Pharmacol 2020;11:531. [PMID: 32410996 DOI: 10.3389/fphar.2020.00531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Sun Y, Bai X, Li L, Zhu G, Tang M. Albiflorin Alleviates Ox-LDL-Induced Human Umbilical Vein Endothelial Cell Injury through IRAK1/TAK1 Pathway. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/6584645] [Reference Citation Analysis]
2 Chen L, Kan J, Zheng N, Li B, Hong Y, Yan J, Tao X, Wu G, Ma J, Zhu W, Sheng L, Chen L, Li B, Zhong J, Du J, Li H. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation. Phytomedicine 2021;91:153693. [PMID: 34403877 DOI: 10.1016/j.phymed.2021.153693] [Reference Citation Analysis]
3 Hu Q, Zhang W, Wu Z, Tian X, Xiang J, Li L, Li Z, Peng X, Wei S, Ma X, Zhao Y. Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects. Pharmacol Res 2021;165:105444. [PMID: 33493657 DOI: 10.1016/j.phrs.2021.105444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Wang T, Zhou X, Kuang G, Jiang R, Guo X, Wu S, Wan J, Yin L. Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1 in mice. J Pharm Pharmacol 2021;73:338-46. [PMID: 33793876 DOI: 10.1093/jpp/rgaa042] [Reference Citation Analysis]
5 Wang XL, Feng ST, Wang YT, Chen NH, Wang ZZ, Zhang Y. Paeoniflorin: A neuroprotective monoterpenoid glycoside with promising anti-depressive properties. Phytomedicine 2021;90:153669. [PMID: 34334273 DOI: 10.1016/j.phymed.2021.153669] [Reference Citation Analysis]
6 Zhang W, Lin H, Cheng W, Huang Z, Zhang W. Protective Effect and Mechanism of Plant-Based Monoterpenoids in Non-alcoholic Fatty Liver Diseases. J Agric Food Chem 2022;70:4839-59. [PMID: 35436113 DOI: 10.1021/acs.jafc.2c00744] [Reference Citation Analysis]
7 Hu Q, Wei S, Wen J, Zhang W, Jiang Y, Qu C, Xiang J, Zhao Y, Peng X, Ma X. Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease. BioData Min 2020;13:11. [PMID: 32863886 DOI: 10.1186/s13040-020-00224-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Tang M, Chen M, Li Q. Paeoniflorin ameliorates chronic stress-induced depression-like behavior in mice model by affecting ERK1/2 pathway. Bioengineered 2021;12:11329-41. [PMID: 34872456 DOI: 10.1080/21655979.2021.2003676] [Reference Citation Analysis]
9 Guo YX, Zhang Y, Gao YH, Deng SY, Wang LM, Li CQ, Li X. Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy. Front Pharmacol 2021;12:639651. [PMID: 34262447 DOI: 10.3389/fphar.2021.639651] [Reference Citation Analysis]
10 Zhang N, Wu Y, Zhong W, Xia G, Xia H, Wang L, Wei X, Li Y, Shang H, He H, Lin S. Multiple anti-non-alcoholic steatohepatitis (NASH) efficacies of isopropylidenyl anemosapogenin via farnesoid X receptor activation and TFEB-mediated autophagy. Phytomedicine 2022;102:154148. [DOI: 10.1016/j.phymed.2022.154148] [Reference Citation Analysis]
11 Wang A, Gong Y, Pei Z, Jiang L, Xia L, Wu Y. Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db/db mice. Int Immunopharmacol 2022;109:108792. [PMID: 35483236 DOI: 10.1016/j.intimp.2022.108792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhou H, Ma C, Wang C, Gong L, Zhang Y, Li Y. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. Eur J Pharmacol 2021;898:173976. [PMID: 33639194 DOI: 10.1016/j.ejphar.2021.173976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wu Y, Qiu G, Zhang H, Zhu L, Cheng G, Wang Y, Li Y, Wu W. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway. J Cell Mol Med 2021;25:9983-94. [PMID: 34664412 DOI: 10.1111/jcmm.16871] [Reference Citation Analysis]
14 Li D, Xu KY, Zhao WP, Liu MF, Feng R, Li DQ, Bai J, Du WL. Chinese Medicinal Herb-Derived Carbon Dots for Common Diseases: Efficacies and Potential Mechanisms. Front Pharmacol 2022;13:815479. [PMID: 35281894 DOI: 10.3389/fphar.2022.815479] [Reference Citation Analysis]
15 Xiong Y, Hu J, Xuan C, Tian J, Tan K, Chen Z, Luo Y, Du X, Cheng J, Zhang L, Cao W. Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats. Chin Med 2021;16:142. [PMID: 34952623 DOI: 10.1186/s13020-021-00552-w] [Reference Citation Analysis]
16 Park K, Kim H, Kim HJ, Lee K, Lee S, Kim J. Paeoniflorin Alleviates Skeletal Muscle Atrophy in Ovariectomized Mice through the ERα/NRF1 Mitochondrial Biogenesis Pathway. Pharmaceuticals 2022;15:390. [DOI: 10.3390/ph15040390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang W, Zhang F, Hu Q, Xiao X, Ou L, Chen Y, Luo S, Cheng Y, Jiang Y, Ma X, Zhao Y. The emerging possibility of the use of geniposide in the treatment of cerebral diseases: a review. Chin Med 2021;16:86. [PMID: 34454545 DOI: 10.1186/s13020-021-00486-3] [Reference Citation Analysis]